Fudan University: Pancreatic Neoplasms trials

The registry lists 49 Pancreatic Neoplasms studies with Fudan University as lead sponsor. 25 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 24Phase 3 11Phase 4 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast CancerNot yet recruitingNCT07825753Phase 2
• Multicentric Database for KRAS Mutant Pancreatic CancerRecruitingNCT07557849
• Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related DiabetesNot yet recruitingNCT07272109Phase 3
• Tamoxifen for Advanced Solid Pseudopapillary Tumor of the PancreasRecruitingNCT06914674Phase 2
• Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic CancerRecruitingNCT06601283Phase 2/3
• Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic CancerRecruitingNCT06598033Phase 2/3
• Exploratory Platform Research on Precision Therapy of Advanced Pancreatic CancerRecruitingNCT06547736Phase 2
• Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic CancerRecruitingNCT06475326Phase 2
• Multi-omics Model for Pancreatic Cancer Screening Using cfDNARecruitingNCT06456281
• Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT06427239Phase 1/2
• Newly Emerging Immunotherapy for Pancreatic Cancer TreatmentNot yet recruitingNCT06370754Phase 1/2
• PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence PatientsRecruitingNCT06359275Phase 2
• The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor SurgeryRecruitingNCT06289803Not applicable
• mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to ChemotherapyRecruitingNCT06249321Phase 2
• HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic CancerNot yet recruitingNCT06217042Phase 3
• Transcatheter Arterial Infusion to Patients With Advanced Pancreatic CancerRecruitingNCT06196788Phase 2
• Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic CancerNot yet recruitingNCT06196671Phase 2
• Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal PancreatectomyNot yet recruitingNCT06167421Not applicable
• A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early DetectionRecruitingNCT06166147
• Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic CancerRecruitingNCT06018896Phase 2
• Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic CancerRecruitingNCT06017284Phase 3
• LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic CancerRecruitingNCT05939063Not applicable
• Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cmRecruitingNCT05907824
• Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPCRecruitingNCT04855331Not applicable
• Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction ChemotherapyRecruitingNCT03398291Phase 3
• Oncologic Safety and Lymphadenectomy in Parenchyma-Sparing Resection for SPNCompletedNCT07592663
• Pancreatic Fistula After Minimally Invasive EnucleationCompletedNCT06557408
• First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC PatientsActive, not recruitingNCT06313970Phase 2
• Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or ReconstructionCompletedNCT06024343Not applicable
• Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic CancerCompletedNCT05840341Phase 3
• A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic CancerStatus unknownNCT05257122Phase 2
• DDP ip Combined With AG in PDAC With Peritoneal MetastasisCompletedNCT05222204Phase 2
• The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer PatientsStatus unknownNCT05168527Phase 2
• A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine RegimenStatus unknownNCT05138159Phase 2
• Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus ChemotherapyStatus unknownNCT04707118Phase 1
• Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic MetastasisStatus unknownNCT04677192Phase 2
• AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic CancerStatus unknownNCT04617821Phase 3
• The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic CancerStatus unknownNCT04581876Phase 2
• Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic CancerStatus unknownNCT04498689Phase 2
• Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer PatientsStatus unknownNCT04217096Phase 4
• Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG RegimenStatus unknownNCT04101929Phase 2
• Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic CancerStatus unknownNCT03929094Phase 2
• Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic CancerStatus unknownNCT03792932Not applicable
• Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal PancreatectomyStatus unknownNCT03659292Not applicable
• Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer SurgeryCompletedNCT03245346Not applicable
• Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionStatus unknownNCT02506842Phase 3
• Left Celiac Plexus Resection for Pancreatic Cancer at the Body and TailStatus unknownNCT02117895Phase 3
• QYHJ Granules Versus Xeloda in Metastatic Pancreatic CancerStatus unknownNCT01796782Phase 2
• Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After PancreaticoduodenectomyCompletedNCT01731821Phase 3